About Internal Medicine Kidney and Hypertension Center
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Ineos Healthcare Limited
1
Pfizer
1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
1
Clinical Trials at Internal Medicine Kidney and Hypertension Center
During the past decade, Internal Medicine Kidney and Hypertension Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Phase 3 Study Comparing the Effects of Intravenous Epoetin Hospira and Epoetin Alfa [Epogen] (Amgen) in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin
2012-01-31
2014-02-11
Completed
612
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Internal Medicine Kidney and Hypertension Center"
#1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Internal Medicine Kidney and Hypertension Center
According to Clinical.Site data, the most researched conditions in "Internal Medicine Kidney and Hypertension Center" are
"Arthritis, Rheumatoid" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Failure" (1 trials) and "Chronic Renal Failure" (1 trials). Many other conditions were trialed in "Internal Medicine Kidney and Hypertension Center" in a lesser frequency.
Clinical Trials Intervention Types at Internal Medicine Kidney and Hypertension Center
Most popular intervention types in "Internal Medicine Kidney and Hypertension Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Epoetin Hospira" (1 trials), "Epogen (Amgen)" (1 trials), "Ibuprofen" (1 trials), "Lanthanum carbonate" (1 trials) and "Magnesium iron hydroxycarbonate" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Internal Medicine Kidney and Hypertension Center
The vast majority of trials in "Internal Medicine Kidney and Hypertension Center" are
3 trials for "All" genders.
Clinical Trials Status at Internal Medicine Kidney and Hypertension Center
Currently, there are NaN active trials in "Internal Medicine Kidney and Hypertension Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Internal Medicine Kidney and Hypertension Center,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Internal Medicine Kidney and Hypertension Center, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".